Australia markets close in 29 minutes

Knight Therapeutics Inc. (KHTRF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.4100+0.0200 (+0.46%)
At close: 03:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 454.78M
Enterprise value 365.09M
Trailing P/E N/A
Forward P/E 303.03
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.90
Price/book (mrq)0.80
Enterprise value/revenue 1.50
Enterprise value/EBITDA 13.09

Trading information

Stock price history

Beta (5Y monthly) 0.46
52-week change 323.53%
S&P500 52-week change 328.04%
52-week high 34.4100
52-week low 33.2010
50-day moving average 34.1198
200-day moving average 33.8040

Share statistics

Avg vol (3-month) 36.5k
Avg vol (10-day) 33.78k
Shares outstanding 5101.38M
Implied shares outstanding 6103.21M
Float 852.24M
% held by insiders 146.36%
% held by institutions 113.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -5.25%
Operating margin (ttm)3.07%

Management effectiveness

Return on assets (ttm)0.21%
Return on equity (ttm)-2.21%

Income statement

Revenue (ttm)332.21M
Revenue per share (ttm)3.17
Quarterly revenue growth (yoy)4.90%
Gross profit (ttm)N/A
EBITDA 49.78M
Net income avi to common (ttm)-17.44M
Diluted EPS (ttm)-0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)192.25M
Total cash per share (mrq)1.9
Total debt (mrq)70.09M
Total debt/equity (mrq)9.20%
Current ratio (mrq)3.34
Book value per share (mrq)7.53

Cash flow statement

Operating cash flow (ttm)62.5M
Levered free cash flow (ttm)44.24M